An International Pilot Study of Oncology Physicians' Opinions and Practices on Complementary and Alternative Medicine (CAM)

Background. In China and Taiwan, Complementary and Alternative Medicine (CAM) therapies such as traditional Chinese medicine have been an option to cancer patients for centuries, whereas in the United States, CAM has been growing in popularity only in the past few decades. Prior research has indicated that the prevalence of CAM use among cancer patients may exceed 80%. Because of a long cultural history of CAM, we hypothesized that oncologists in China and Taiwan (C/T) would communicate and combine CAM with conventional treatments more often than US oncologists. Methods. In 2004-2005, a convenience sample of oncologists from the United States, mainland China, and Taiwan were surveyed regarding their opinions and self-reported practice patterns regarding CAM. Results. A total 95 oncologists returned surveys, providing a 38% response rate. Four out of 5 respondents (78%) felt their medical training was inadequate to use CAM. However, 70% reported they would allow CAM use during active cancer treatment, even in the setting of curable disease. Responding C/T oncologists tended to ask patients more frequently (they ask > 25% of patients) about CAM use and recommended CAM more commonly (recommend to > 10%) to patients than surveyed US oncologists, 55% versus 37% (P = .09) and 81% versus 53% (P < .05). Respondents from the United States felt no more prepared for CAM use than C/T respondents, but 70% reported willingness to combine CAM with conventional treatments for curable disease as compared with only 48% (P < .05) of C/T oncologists. Conclusions. As expected, responding C/T oncologists communicate more often about CAM with patients by asking and recommending CAM. However, contrary to our original hypothesis, C/T oncologists reported a much lower rate of combining CAM with conventional treatment among curable patients than responding US oncologists. Further research is needed to explore, in depth, the reasons for differences in CAM practice patterns among oncologists.

[1]  H. Boon,et al.  Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005 , 2007, BMC women's health.

[2]  A. Bardia,et al.  Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Lussier,et al.  Doctor-patient communication : Time to talk , 2006 .

[4]  J. Schellens,et al.  Herb-drug interactions in oncology: focus on mechanisms of induction. , 2006, The oncologist.

[5]  K. Eguchi,et al.  Nationwide survey on complementary and alternative medicine in cancer patients in Japan. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Sloan,et al.  Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Mary Ann Richardson,et al.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine , 2004, Supportive Care in Cancer.

[8]  M. McGrail,et al.  Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. , 2004, Complementary therapies in medicine.

[9]  P. Barnes,et al.  Complementary and alternative medicine use among adults: United States, 2002. , 2004, Advance data.

[10]  D. Clouatre.  Kava kava: examining new reports of toxicity. , 2004, Toxicology letters.

[11]  R. Livingston,et al.  Potential of chemotherapy–herb interactions in adult cancer patients , 2004, Supportive Care in Cancer.

[12]  K. Eguchi,et al.  Perceptions and attitudes of clinical oncologists on complementary and alternative medicine , 2003, Cancer.

[13]  A. Vickers,et al.  Does use of alternative medicine predict survival from cancer? , 2003, European journal of cancer.

[14]  S. Straus,et al.  Complementary and alternative medicine: opportunities and challenges for cancer management and research. , 2002, Seminars in Oncology.

[15]  H. Shapiro,et al.  Physicians want education about complementary and alternative medicine to enhance communication with their patients. , 2002, Archives of internal medicine.

[16]  G. Maskarinec,et al.  Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives , 2002, Psycho-oncology.

[17]  E. Ernst.  Toxic heavy metals and undeclared drugs in Asian herbal medicines. , 2002, Trends in pharmacological sciences.

[18]  E. Ernst,et al.  Heavy metals in traditional Chinese medicines: A systematic review , 2001, Clinical pharmacology and therapeutics.

[19]  K. Antman,et al.  Introduction: the history of arsenic trioxide in cancer therapy. , 2001, The oncologist.

[20]  S. Singletary,et al.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Münstedt,et al.  The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). , 1999, European journal of cancer.

[22]  J. Sugarman,et al.  Physicians' ethical obligations regarding alternative medicine. , 1998, JAMA.

[23]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[24]  P. Pandolfi,et al.  Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide , 2001 .

[25]  E. Ernst.  The prevalence of complementary/Alternative medicine in cancer , 1998, Cancer.

[26]  T Hesketh,et al.  Health in China: Traditional Chinese medicine: one country, two systems , 1997, BMJ.

[27]  Wei Tang,et al.  Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.

[28]  J. Whang‐Peng,et al.  Cross sectional study of use of alternative medicines in Chinese cancer patients. , 1997, Japanese journal of clinical oncology.

[29]  E. Crocetti,et al.  Complementary Medicine and Oncologists’ Attitudes: A Survey in Italy , 1996, Tumori.

[30]  F. Pfab.  Acupuncture-Point Stimulation for Chemotherapy-Induced Nausea and Vomiting , 2006 .

[31]  L. J. Schelven.  Herbal remedies in the United States: potential adverse interactions with anticancer agents , 2004 .

[32]  P. Barnes,et al.  Complementary and alternative medicine use among adults: United States, 2002. Advance data from vital and health statistics, no. 343 , 2004 .